Indications
Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma.
Composition
- Active substance
- travoprost
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Izba
- Active substance
- travoprost
- ATC code
- S01EE04
- Group
- Sensory organs
- Therapeutic area
- Ocular Hypertension, Glaucoma, Open-Angle
- Marketing authorisation holder
- Novartis Europharm Limited
- Status
- Authorised